Newswise Feature Channel: Men's Health

Study Uncovers Key Role of RNA Modifications in Prostate Cancer Progression

University of California, Los Angeles (UCLA), Health Sciences — Mon, 24 Mar 2025 10:40:41 EST

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny chemical modification in RNA, known as m6A, plays a critical role in the progression of prostate cancer, including driving some of its most dangerous forms of the disease.

Study Confirms Safety and Efficacy of Higher-Dose-Per-Day Radiation for Early-Stage Prostate Cancer

University of California, Los Angeles (UCLA), Health Sciences — Tue, 18 Mar 2025 18:40:09 EST

A new large-scale study provides the strongest evidence yet that a shorter, standard-dose course radiation treatment is just as effective as conventional radiotherapy for prostate cancer, without compromising the safety of patients.

Artificial Intelligence Tool Helps Predict Who Will Benefit From Focal Therapy for Prostate Cancer

University of California, Los Angeles (UCLA), Health Sciences — Tue, 18 Mar 2025 10:35:43 EST

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most likely to benefit from partial gland cryoablation, a minimally invasive procedure that treats localized prostate tumors.

Prostate Cancer Is Not a Death Knell, Study Shows

UW Medicine — Mon, 10 Mar 2025 19:50:24 EST

"Being diagnosed with prostate cancer is not a death knell," said Montgomery, senior author of a literature and trial review that appeared in JAMA today. Montgomery is the clinical director of Genitourinary Oncology at Fred Hutch Cancer Center and University of Washington Medical Center, and a professor of medicine and urology at the UW School of Medicine.

Unraveling the Mysteries of Male Infertility

Rutgers University-New Brunswick — Wed, 05 Mar 2025 19:30:45 EST

A genetic mutation in mice affects cells required for sexual reproduction and holds clues about male infertility that could pave the way for new treatments and male contraceptives, a Rutgers University-New Brunswick researcher and colleagues have discovered. Writing in Nature Communications, Devanshi Jain, an assistant professor with the Department of Genetics at the School of Arts and Sciences, addresses a fundamental question about how humans and animals develop germ cells that go on to form sperm.

Study Uncovers Genetic Drivers of Aggressive Prostate Cancer

University of California, Los Angeles (UCLA), Health Sciences — Mon, 03 Mar 2025 20:25:31 EST

Scientists from UCLA, the University of Toronto and the University of Melbourne have uncovered new genetic clues that explain why some prostate cancers remain slow-growing while others become life-threatening.

MD Anderson Research Highlights for February 26, 2025

University of Texas MD Anderson Cancer Center — Wed, 26 Feb 2025 16:45:20 EST

The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

New Cancer Vaccine Method Boosts Potency and Scope

Tufts University — Mon, 24 Feb 2025 17:55:15 EST

Researchers have developed a cancer vaccine method that can target virtually any solid tumor, amplifying the visibility of tumor antigens to the immune system, leading to a potent response. Preclinical tests shows that it helps slow or stop the progression of melanoma, triple-negative breast cancer, lung and ovarian cancer

Dana-Farber Researchers Present Findings at 2025 ASCO Genitourinary Cancers Symposium

Dana-Farber Cancer Institute — Tue, 11 Feb 2025 19:55:06 EST

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) Cancers Symposium, on February 13-15, 2025. The Dana-Farber led research exemplifies innovative and multidisciplinary expertise in prostate, kidney, and bladder cancers, and includes studies examining novel treatments and predictive biomarkers.

What Cancers Can You Be Screened for, When and How?

Rutgers Cancer Institute — Mon, 10 Feb 2025 17:30:26 EST

February is National Cancer Prevention Month. Cancer screenings are essential for detecting cancer early--often before symptoms appear--when treatment is most effective. Learn more about what cancers you can be screened for and when.

Why Do Women Have More Trouble After Knee Injuries? UTSW Model Explains

UT Southwestern Medical Center — Wed, 05 Feb 2025 10:55:14 EST

A computer model of the cellular environment inside the knee developed by UT Southwestern Medical Center researchers sheds light on why women tend to have worse outcomes after knee injuries than men. Their findings, published in Scientific Reports, could facilitate research into new therapies for knee inflammatory disorders and personalized treatments for patients with these conditions.

Study Shows Urine Test for Prostate Cancer Could Be Used at Home

Vanderbilt University Medical Center — Mon, 03 Feb 2025 08:00:00 EST

Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancer screening is highly accurate. The exciting new results, published in The Journal of Urology, build upon a prior Vanderbilt study of prostate cancer screening that required a digital rectal exam.

UCLA-Led Study Establishes Link Between Early Side Effects From Prostate Cancer Radiation and Long-Term Side Effects

University of California, Los Angeles (UCLA), Health Sciences — Fri, 31 Jan 2025 19:30:38 EST

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, according to a new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center.

Urine-Based Test Detects Aggressive Prostate Cancer

Michigan Medicine - University of Michigan — Tue, 28 Jan 2025 20:30:50 EST

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being uncomfortable, some of these procedures result in overdiagnosis of low-grade cancers.

Inherited Gene Elevates Prostate Cancer Risk in Affected Families

Vanderbilt University Medical Center — Tue, 28 Jan 2025 16:00:00 EST

The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to the Vanderbilt University Medical Center study published in JCO Precision Oncology.

The Mount Sinai Hospital Becomes First in NYC to Offer Advanced HYDROS(tm) Robotic System for Treating Enlarged Prostates

Mount Sinai Health System — Mon, 27 Jan 2025 09:00:54 EST

The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS(tm) Robotic System, a cutting-edge technology designed to treat benign prostatic hyperplasia (BPH), or an enlarged prostate. The minimally invasive procedure offers new hope for patients experiencing the symptoms of BPH, including frequent urination, incomplete bladder emptying, and nighttime urgency. Urologists at the hospital recently performed the health system's first three procedures, with all patients responding well to the treatment and being discharged the following day.

Moffitt Study Shows How Genomic Tests Could Help Treat Prostate Cancer More Effectively

Moffitt Cancer Center — Fri, 24 Jan 2025 10:20:25 EST

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests -- Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris -- can help doctors make better decisions about how to treat patients with early stage prostate cancer. The review, published in the Annals of Internal Medicine, shows that these tests can provide more detailed information about the cancer, but experts say more data is needed on the cost-effectiveness and clinical utility of these tests, as well as their impact on racial and ethnic groups, especially Black men.

Advancing Prostate Cancer Care: Insights From Chinese Experts

Chinese Academy of Sciences — Mon, 20 Jan 2025 04:30:31 EST

Prostate cancer is rapidly emerging as a significant health challenge in China, with the incidence rate steadily rising. A group of distinguished Chinese experts has recently developed a comprehensive consensus aimed at addressing critical gaps in prostate cancer management, particularly in areas where high-level evidence is currently lacking. This consensus is designed to guide clinical practice, from screening to treatment and follow-up, offering a standardized approach to improve patient outcomes across the country.

ACS Annual Report: Cancer Mortality Continues to Drop Despite Rising Incidence in Women; Rates of New Diagnoses Under 65 Higher in Women Than Men

American Cancer Society (ACS) — Thu, 16 Jan 2025 18:50:03 EST

The American Cancer Society today released Cancer Statistics, 2025, the organization's annual report on cancer facts and trends. The new findings show the cancer mortality rate declined by 34% from 1991 to 2022 in the United States, averting approximately 4.5 million deaths.

UTHealth Houston Research: Children Born to Young Men with Cancer Have Slight Increases in Preterm Birth, Low-Birth-Weight Children, but Not Birth Defects

University of Texas Health Science Center at Houston — Thu, 16 Jan 2025 17:25:08 EST

Male adolescents and young adults with cancer have a slightly elevated risk of having preterm birth and children with low birth weight, but no increased risk of birth defects in their offspring, according to research by UTHealth Houston. The population-based study was recently published in the Journal of the National Cancer Institute.